PI-LAB-2025-111

Tesamorelin, Independent Lab Report

Tesamorelin 5mg · Cascade Research Group

Failed

Independent testing verdict Fail

This product failed independent verification.

Sample failed verification: 57.8% measured purity against a ≥98% claim, with 98.5% of labelled content.

Identity verified
No

The labelled compound was not confirmed

Measured purity
57.8%

Label claimed ≥98%

Content accuracy
98.4%

4.92mg measured against 5mg claimed

Test recency
Older result

Published 16 months ago

Specimen PI-LAB-2025-111 Tested by Meridian Bioanalytical 9 samples tested from this company Purity & Testing score 9/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 57.8% Fails claim
Identity (MS) Tesamorelin Not confirmed Identity failure
Content 5 mg 4.92 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Meridian Bioanalytical. See our full testing methodology.

Lot / batch
R2617-25
Purchased
Analysed
Published
Laboratory
Meridian Bioanalytical
Test type
Purity & identity

Testing notes

Result confirmed on a second sample from a separate lot at a second laboratory before publication.

Original laboratory report: PI-LAB-2025-111-report.pdf (document delivery arrives with the production storage backend)

More Tests, Cascade Research Group

Semaglutide
Purity 96.1% Discrepancy
Semaglutide
Purity 58.1% Failed
BPC-157
Purity 61.0% Failed